ump8k103008.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): October 30, 2008


Commission File No. 0-11178


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)


7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:   (801) 566-1200

 
 
 
 

ITEM 8.01 OTHER EVENTS

 
On October 30, 2008, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend.  A dividend of $.230 per share is payable on January 5, 2009 to shareholders of record at the close of business on December 16, 2008.  A copy of the press release is attached hereto as Exhibit 99.1
 
 

SIGNATURES
 
 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
     
Date:         10/30/2008       
By:
   /s/ Kevin L. Cornwell   
   
Kevin L. Cornwell
   
CEO




 
EXHIBIT INDEX

Index
  
Number
Description